The homeotic or Hox genes encode a network of conserved transcription factors which provide axial positional information and control segment morphology in development and evolution. During embryonic brain development of Drosophila, the Hox gene labial (lab) is essential for tritocerebral neuromere specification; lab loss of function results in tritocerebral cells that fail to adopt a neuronal identity, causing axonal pathfinding defects. Here we present evidence that the POU-homeodomain DNA-binding protein ventral veins lacking (vvl) acts genetically downstream of lab in the specification of the tritocerebral neuromere. In the embryonic brain, vvl expression is seen in all brain neuromeres, including the tritocerebral lab domain. Lab mutant analysis shows that vvl expression in the tritocerebrum is dependent on lab activity. Loss-offunction analysis focussed on the tritocerebrum reveals that inactivation of vvl results in patterning defects which are comparable to the brain phenotype caused by null mutation of lab. In the absence of vvl, mutant tritocerebral cells are generated and positioned correctly, but these cells fail to express neuronal markers indicating defects in neuronal differentiation. Moreover, longitudinal axon pathways in the tritocerebrum are severely reduced or absent and the tritocerebral commissure is missing in the vvl mutant brain. Genetic rescue experiments show that vvl is able to partially replace lab in the specification of the tritocerebral neuromere. Our results indicate that vvl acts downstream of the Hox gene lab and regulates specific aspects of neuronal differentiation within the tritocerebral neuromere during embryonic brain development of Drosophila. q
Introduction
The Hox/homeotic genes encode homeodomain transcription factors that generate morphological diversity along the major body axis during animal development (Gellon and McGinnis, 1998; Schilling and Knight, 2001; Angelini and Kaufman, 2005) . In Drosophila, Hox genes display a chromosomal arrangement in two gene clusters, the Antennapedia and Bithorax complexes. The relative position of the Hox genes within each cluster correlates with their spatial and temporal expression pattern along the anteroposterior body axis, in that genes located towards the 3 0 end are expressed more anterior and earlier than genes located towards the 5 0 end (spatial and temporal colinearity) (Mann and Morata, 2000; Angelini and Kaufman, 2005) .
In the developing brain and ventral nerve cord (VNC) of Drosophila, Hox genes are expressed in an ordered set of domains (Hirth et al., 1998) . In the embryonic brain, genes of the Antennapedia complex are expressed in the deutocerebrum and tritocerebrum as well as in the three subesophageal neuromeres. The tritocerebrum is the posterior neuromere of the supraesophageal ganglion, consisting of two bilaterally symmetric hemiganglia that are linked by the tritocerebral commissure which runs across the midline beneath the gut (Burrows, 1996; Reichert and Boyan, 1997; Boyan et al., 2003) . The tritocerebrum is connected to anterior and posterior parts of the brain through longitudinal connectives and forms projections to the frontal ganglion via the frontal connectives. The Hox gene that is specifically expressed in the tritocerebrum is labial (lab). Null mutations of lab cause profound defects in axonal patterning and cell specification of the tritocerebral neuromere (Hirth et al., 1998 (Hirth et al., , 2001 Page, 2000; Sprecher et al., 2004) . In lab loss-of-function mutants, the tritocerebral commissure is missing and the longitudinal connectives that interconnect the tritocerebrum with the deutocerebrum and mandibular neuromere, are reduced or absent. Moreover, the cells in the lab mutant domain neither express neuronal markers nor extend axons, indicating a complete lack of neuronal identity. These results suggest that lab is required for the specification of segmental neuronal identity in the tritocerebral neuromere. Given their central role in developmental processes such as brain neuromere specification (Hirth and Reichert, 1999) , it has been long recognized that Hox proteins accomplish the specification of morphological characters by controlling a battery of subordinate targets, the Hox realizator genes, which regulate cellular functions directly required in differentiation (GarciaBellido, 1975; Graba et al., 1997; Pradel and White, 1998; Mann and Carroll, 2002; Merabet et al., 2005) . In search of these subordinate targets of the Hox gene lab, we recently exploited oligonucleotide array transcript imaging following lab overexpression in Drosophila embryos (Leemans et al., 2001) . We found significant changes in gene expression for 96 identified genes following lab overexpression, suggesting that some of these genes might represent potential direct or indirect downstream target genes for Lab. The functional class with the highest absolute number of differentially regulated genes was transcriptional regulation. Among the genes in this class was ventral veins lacking (vvl), previously referred to as Cf1a or drifter, which encodes a POU-homeodomain DNA-binding protein (Johnson and Hirsh, 1990; Treacy et al., 1991; Anderson et al., 1995) .
During Drosophila embryogenesis, vvl expression is seen in the developing tracheal system, and in the oenocytes. Moreover, vvl expression is also detectable in the central nervous system (CNS) in a uniform repeated pattern of w25 nuclei per neuromere grouped into five distinctive clusters: a midline cluster of four nuclei containing midline glia and motoneurons, two symmetrical mediolateral clusters that contain the paired serotonergic neurons, and two symmetrical lateral clusters (Anderson et al., 1995; Certel and Thor, 2004) . Loss of function analyses revealed that vvl is required for the proper development of the tracheal system and specific structures in the CNS (Anderson et al., 1995) . Specifically, in the CNS, homozygous null mutant embryos display aberrantly localized midline glia, extensive malformation of the longitudinal connectives as well as fused or irregular spaced commissures in the VNC (Anderson et al., 1995) .
In addition to its expression in the VNC, vvl is also expressed in the embryonic brain of Drosophila, however, currently nothing is known about a possible role of vvl in brain development (Treacy et al., 1991; Billin et al., 1991; Anderson et al., 1995) . To investigate this possibility, and to determine whether vvl might indeed act as a downstream target of the Hox gene lab, we have used immunocytochemical and genetic methods to study vvl action in embryonic brain development of Drosophila. A functional analysis of vvl focussed on the tritocerebral neuromere shows that vvl mutant tritocerebral cells exhibit defects in neuronal differentiation as indicated by the lack of neuronal marker gene expression. In addition, vvl mutant brains display severe axonal patterning defects which resemble those seen in lab mutants. Using loss-of-function and genetic rescue experiments we show that vvl activity in the tritocerebral brain neuromere is dependent on the Hox gene lab and is able to rescue specific aspects of the lab mutant brain phenotype. Taken together, our results suggest that vvl acts genetically downstream of the Hox gene lab in the specification of tritocerebral neuronal identity during embryonic brain development of Drosophila.
Results and discussion
An initial characterization of vvl gene expression during embryogenesis has been carried out previously using wholemount in situ hybridization (Treacy et al., 1991; Billin et al., 1991; Anderson et al., 1995) . This analysis showed that vvl is expressed in the embryonic brain from the extended germ band stage onwards. For an analysis of the protein distribution pattern of vvl in the embryonic brain, immunocytochemical experiments with a polyclonal antibody against the VVL protein were carried out in combination with an anti-HRP antibody; anti-HRP immunoreactivity reveals the entire neural lineage of the developing CNS excluding the glial lineage (Jan and Jan, 1982) . At late stage 11, vvl expression was first detected in few neuroblasts of the developing brain anlage, and by stage 13 became abundant in neuroblasts and their progeny within each brain neuromere. By stage 15, when neural progeny were generated and axonal projections were formed, VVL protein was observed in specific cell clusters within all brain neuromeres (Fig. 1A) . Accordingly, a prominent expression domain was also observed in the developing tritocerebrum (Fig. 1A, arrow) .
Expression of vvl in the tritocerebrum suggested a possible overlap with the expression of the Hox gene lab. To investigate this, double-immunocytochemical experiments were carried out either on transgenic flies expressing a lab-lacZ reporter construct in which antibodies against VVL were used together with anti-bgal antibodies (Fig. 1B) , or on wildtype embryos in which antibodies against VVL were used together with anti-LAB antibodies (Fig. 3A) . These experiments revealed that the majority of cells expressing vvl in the tritocerebrum were located within the lab expression domain (Fig. 1B, arrow; Fig. 3A, arrow) . Together with our earlier observation that vvl appears to be differentially regulated by lab (Leemans et al., 2001) , the co-expression of lab and vvl in the tritocerebrum suggested that vvl activity might be lab-dependent in this neuromere. To study this further, we investigated whether mutational inactivation of lab affects vvl expression in the tritocerebrum.
Mutational inactivation of lab results in regionalized axonal patterning defects which are due to both cell-autonomous and cell-nonautonomous effects. Thus, in the absence of lab, mutant cells are generated and positioned correctly in the brain, but these cells do not extend axons. Additionally, extending axons of neighboring wildtype neurons stop at the mutant domains or project ectopically, resulting in the disruption of the longitudinal connectives and a lack of the tritocerebral commissure (Hirth et al., 1998 (Hirth et al., , 2001 Page, 2000) . To characterize vvl expression in a lab-/-background, we carried out double-immunocytochemical experiments on homozygous lab null mutant embryos using antibodies against VVL and HRP (Fig. 1C) . These experiments revealed that vvl immunoreactivity is lacking in the tritocerebral lab mutant domain (Fig. 1C, arrow) , in addition to the expected lack of anti-HRP immunoreactivity despite the persistence of cells in this region (for a detailed description of the lab mutant brain phenotype see Hirth et al., 1998 Hirth et al., , 2001 ). This suggested that vvl expression in the posterior tritocerebrum was affected by loss of lab function during late stages of embryonic brain development, indicating that vvl expression in the tritocerebrum is labdependent.
To assess the functional role of vvl in tritocerebral neuromere formation, vvl null mutants were analyzed using immunocytochemical markers including anti-HRP, anti-ELAV, anti-REPO, and anti FASII, which label general neuronal (or glial) domains and tracts in the developing embryonic brain. In vvl loss-of-function mutants, a pronounced brain phenotype was observed in the late stage embryonic brain. Immunolabelling with neuron-specific anti-HRP and anti-FASII antibodies identified a gap separating the deutocerebral brain region from the neuromeres of the more posterior subesophageal ganglion ( Fig. 2A, B ). This dramatic phenotype was associated with severe axonal patterning defects in the embryonic brain. The longitudinal connectives that normally run from the deutocerebral and tritocerebral neuromeres to the subesophageal ganglion were severely reduced or missing ( Fig. 2A, B , G, H, arrows) and the tritocerebral commissure, which interconnects the brain hemispheres at the level of the tritocerebrum, was completely absent (Fig. 2C, D , arrowheads). Analysis of FASII immunoreactivity revealed that descending and ascending axons which in the wildtype normally project through the tritocerebrum in well formed fascicles, failed to project through this domain in vvl mutants ( Fig. 2A, B) . Moreover, we observed a loss of anti-ELAV immunolabelling in the tritocerebral domain (Fig. 2E, F) , whereas glia-specific anti-REPO immunoreactivity revealed that glial cells were present in the vvl mutant but failed to be correctly localized in the affected region (Fig. 2G, H) . In addition to the observed defects in the tritocerebral brain region, marked axonal patterning defects in the protocerebrum were also seen in vvl mutant embryos. Moreover the organization of the suboesophageal ganglion and the VNC was affected in the vvl mutant. These latter two phenomena were not studied further.
At the gross histological level, the vvl mutant brain phenotype described above was, in part, reminiscent of the mutant brain phenotype observed for lab. Since lab and vvl showed overlapping expression in the tritocerebral neuromere, and vvl expression was lacking in lab mutants, these findings suggested that either lab expression itself or lab expressing tritocerebral cells were affected in vvl mutant embryos. To investigate this we first carried out anti-LAB immunolabelling in late vvl loss-of-function mutant brains. Surprisingly, despite the expected lack of expression of neuronal differentiation markers (see Fig. 2 ), anti-LAB immunolabelling was detected in a wildtype-like pattern in the vvl mutant tritocerebral domain (Fig. 3) . This suggested that the expression of lab was not affected in the absence of vvl during late stages of embryonic brain development (Fig. 3D) . Moreover, the lab expressing cells in the vvl mutant generally had the same relative position in the brain as did the normal lab expressing cells in the wildtype (Fig. 3B, D) . Thus, despite the severe axonal patterning defects observed in this domain, mutant cells were generated and appeared to be properly positioned in the developing tritocerebrum of the vvl null mutant. This, in turn, suggested that the pattern of proliferation in the tritocerebrum was initiated correctly in the absence of the vvl gene product, but that the cells that normally express vvl might become 
(E, F) double immunolabeling with anti-ELAV (green) and anti-HRP (red). (G, H) Double immunolabeling with anti-HRP (red) and anti-REPO (yellow/green).
In vvl mutants, longitudinal axon pathways in the tritocerebrum are severely reduced or absent (arrow in B; compare to A) and the tritocerebral commissure is always missing (D, arrowhead; compare to C). Fasciclin II, which in the wildtype is expressed in descending and ascending axons that normally project through the tritocerebrum in well formed fascicles (arrow in A), fail to project through this domain in vvl mutants (arrow in B). In vvl mutants, the lineage specific marker HRP (arrow in B, F, H; compare to A, E, G) as well as the neuron specific marker ELAV (arrow in F; compare to E) are missing in the tritocerebral domain. In vvl mutants, the glia-specific marker REPO is expressed in cells of the tritocerebral domain (arrow in H; compare to wildtype, arrow in G).
incorrectly specified in the vvl mutant leading to axogenesis defects. Moreover, the lack of anti-ELAV and anti-HRP immunolabelling together with the observed severe fasciculation defects in the vvl mutant tritocerebrum (see Fig. 2 ) strongly suggest that mutational inactivation of vvl affects neuronal differentiation in the developing tritocerebrum.
These data imply that vvl might be involved in the specification of tritocerebral neuronal identity-either by acting directly or indirectly downstream of tritocerebral lab activity. To further assess a possible lab-dependent vvl activity in the developing tritocerebrum, we determined the potential of vvl to rescue the lab mutant brain phenotype using the Gal4-UAS system (Brand and Perrimon, 1993) . For this, a transgenic fly line carrying a Gal4 transcriptional activator under the control of the lab promoter together with CNS-specific upstream enhancer elements of the lab gene was used. By crossing this lab::Gal4 line to different UAS-responders it was possible to express the responder constructs in a pattern that corresponded to that of the endogenous lab gene. Using this approach, we have previously shown that the lab mutant brain phenotype could be rescued by transgenic expression of the Lab protein in a lab null mutant background (Hirth et al., 2001 ). To determine whether vvl might also be able, at least in part, to rescue the lab mutant brain defects, a transgenic UAS::vvl line was used in which the vvl coding sequence was placed under UAS control (Certel et al., 2000) .
As a control, we first determined whether lab::Gal4 driven misexpression of vvl in a labCbackground had any effects on the development and specification of the tritocerebral Lab domain. In none of these experiments did we detect morphological abnormalities in the tritocerebrum or in any other part of the embryonic brain (data not shown). We then expressed the UAS::vvl responder under the control of the lab:: Gal4 driver in the lab mutant domain. Remarkably, the VVL protein was able to rescue specific lab mutant brain defects as shown in Fig. 4 . Thus, the longitudinal pathways were restored and cells in the mutant domain showed wildtype-like anti-HRP immunolabelling (Fig. 4A, E, I ). Moreover, FASII immunoreactivity revealed that descending and ascending axons from other parts of the brain again projected through the tritocerebral lab mutant domain (Fig. 4B, F, K) . The vvl responder achieved a rescue efficiency (97.3%, NZ70) which was comparable to the rescue efficiency of Lab, which was taken as 100% (NZ 132; see Hirth et al., 2001 ). In contrast, lab::Gal4-specific expression of vvl in the lab mutant domain did not rescue tritocerebral commissure formation, nor correct axonal projection of the frontal connective (Fig. 4C, G, L) , arrowheads). This suggested that lab::Gal4 driven misexpression of vvl is sufficient to restore both neuronal marker gene expression like HRP and correct axonal patterning of longitudinal connectives in the lab mutant tritocerebrum. These findings together with the vvl mutant brain phenotype indicate that vvl acts genetically downstream of lab in the specification of the triocerebral neuromere.
Taken together, these findings demonstrate that vvl function is required for the specification of the developing tritocerebrum. The vvl gene is important for correct axon guidance and fasciculation of longitudinal connectives in the tritocerebral neuromere. In the absence of vvl, longitudinal and commissural axon pathways are severely affected. Comparable findings have been reported for the role of vvl in VNC development, where vvl mutant embryos exhibit aberrantly localized midline glia and axonal defects in that commissures are often fused and the longitudinal connectives are severly reduced or even disrupted (Anderson et al., 1995) . Our findings suggest that vvl acts genetically downstream of the Hox gene lab in the control of regionalized neuronal identity and tritocerebral brain neuromere specification. In accordance with this notion is the successive time of lab and vvl expression in the tritocerebral neuromere. From stage nine onwards, lab expression commences in the intercalary segment and by early stage 11, lab is detected in all neuroblasts of the developing tritocerebrum Urbach and Technau, 2003) . Accordingly, by late stage 11, vvl expression is first seen in the tritocerebral neuromere and thus succeeds initial lab expression. Interestingly, this time of initial vvl expression exactly coincides with the temporal requirement of lab for tritocerebral neuronal fate specification (Page, 2000) . Moreover, our results demonstrate that tritocerebral vvl expression is lab-dependent. In addition, in vvl mutants, lab is expressed normally in the tritocerebrum and yet cells in the affected tritocerebral domain phenocopy the lab mutant brain and do not express molecular markers characteristic of neuronal cells. Furthermore, the vvl gene can mediate neuronal specification and longitudinal connective formation in the absence of the Hox gene lab if expressed under appropriate spatiotemporal control. This indicates that vvl is required for the specification of neuronal identity in the tritocerebral lab domain and sufficient to provide a permissive substrate for the migration of axons originating from outside this region (Page, 2000) . However, vvl cannot rescue tritocerebral commissure formation in the lab mutant brain. This inicates that lab exerts at least some of its effects on tritocerebral development through other subordinate genes than vvl.
Experimental procedures

Drosophila strains and genetics
The wildtype was Oregon-R. Null mutant alleles were: lab vd1 and vvl dfr-E82 (Anderson et al., 1995) , balanced either over TM3, UbxlacZ or TM6B, Ubx-lacZ; homozygous null mutants were identified by the absence of Ubx-lacZ. To identify former lab expressing tritocerebral cells in the lab and vvl mutant background, we used line p[w C , 3.6 lab-lacZ] either crossed into the lab vd1 or the vvl dfr-E82 mutant background, balanced over TM6b-UbxlacZ (Chouinard and Kaufman, 1991; Hirth et al., 2001) . Homozygous null mutants were identified by the absence of Ubx-lacZ. 3.6 lab-lacZ shows nuclear distribution of bgal and reflects endogenous lab expression in the embryonic head ectoderm, tritocerebrum, and posterior midgut (Hirth et al., 2001 ).
For lab::Gal4 specific targeted misexpression of vvl in lab mutant embryos, the P{w C lab::Gal4}K5J2 driver line (Hirth et al., 2001 ) and the p[UAS::vvl.C/ CyO] (Certel et al., 2000) responder line were used. Control experiments verified that the P{w C lab::Gal4}K5J2 driver is expressed in a spatial pattern, which corresponds to that of endogenous lab in the procephalon, and in the tritocerebral neuromere (Hirth et al., 2001) . UAS::transgene activation in the procephalon is delayed for 2.5 h as compared to earliest presence of endogenous Lab protein (Kaufman et al., 1990) , thus under the control of P{w C lab::Gal4}K5J2, UAS::responder activation starts at late stage 10 (5-5.5 h AEL; Campos-Ortega and Hartenstein, 1997). Phenotypic penetrance of the lab mutant brain phenotype was 88.6% (nZ209) as determined with the lab null allele lab vd1 Hirth et al., 1998) using flies of the genotype lab vd1 /TM6B-UbxlacZ. All strains as well as all experimental genotypes were maintained in standard laboratory cultures at 25 8C. Embryos were staged according to Campos-Ortega and Hartenstein (1997) .
Immunocytochemistry and genetic rescue analysis
Whole-mount immunocytochemistry was performed as previously described (Hirth et al., 1998 (Hirth et al., , 2001 . Primary antibodies were a preadsorbed rat anti-DFR serum 1:2000 (Anderson et al., 1995 ; kindly provided by Johnson) rabbit anti-HRP (FITC-conjugated) 1:100 (Jan and Jan, 1982 ) (Jackson Immunoresearch), rabbit anti-LAB at 1:100, rat anti-LAB at 1:500, rabbit antibetaGAL 1:200-1:400 (Milan Analytika), mouse anti-betaGAL 1:50 (DSHB), mouse anti-Fasciclin II 1:5 (Lin and Goodman, 1994) , rat anti-ELAV 1:30 (DSHB), mouse anti-REPO 1:20 (Halter et al., 1995; Campbell et al., 1994; DSHB) , mouse anti-Engrailed (4D9,1:6, Patel et al., 1989; DSHB) . Secondary antibodies used for confocal microscopic analysis were Alexa-488, Alexa-568, and Alexa-647 antibodies generated in goat (Molecular probes), all at 1:150 dilution. Embryos were mounted in Vectashield H-1000 (Vector).
In genetic rescue experiments, P{w C lab::Gal4}K5J2 driven P{UAS:: vvl.C} activity in homozygous lab null mutants (lab vd1 /lab vd1 ) was confirmed by the absence of balancer-specific (TM6B-UbxlacZ) b-gal and/or Labial immunoreactivity as well as by the presence of anti-VVL/DFR immunoreactivity in the tritocerebral lab domain. The criteria used to judge lab K/K embryos as fully rescued were (1) the presence of the tritocerebral commissure linking the two tritocerebral hemiganglia, (2) the restoration of the longitudinal pathways between the supra-and subesophageal ganglia, and (3) the expression of neuron-specific molecular labels as assayed by anti-HRP and anti-Elav immunoreactivity (Hirth et al., 1998 (Hirth et al., , 2001 . Only when all three criteria were fulfilled, the tritocerebrum of a lab -/-mutant embryo was scored as fully rescued. A partial rescue was achieved when at least the restoration of the longitudinal pathways between the supra-and subesophageal ganglia occurred.
Laser confocal microscopy
For laser confocal microscopy, a Leica TCS SP was used. Optical sections ranged from 0.4 to 2 mm recorded in line average mode with picture size of 512!512 pixels. Captured images from optical sections were arranged and processed using IMARIS (Bitplane). Figures were arranged and labeled using Adobe Photoshop.
